UBS Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.5M | Buy |
|
|||||
|
2025
Q2 | $1.06M | Sell |
|
|||||
|
2025
Q1 | $4.74M | Sell |
|
|||||
|
2024
Q4 | $5.88M | Buy |
|
|||||
|
2024
Q3 | $807K | Buy |
|
|||||
|
2024
Q2 | $368K | Sell |
|
|||||
|
2024
Q1 | $435K | Buy |
|
|||||
|
2023
Q4 | $316K | Buy |
|
|||||
|
2023
Q3 | $138K | Buy |
|
|||||
|
2023
Q2 | $8.79K | Sell |
|
|||||
|
2023
Q1 | $77.9K | Buy |
|
|||||
|
2022
Q4 | $34.7K | Buy |
|
|||||
|
2022
Q3 | $23K | Buy |
|
|||||
|
2022
Q2 | $5K | Sell |
|
|||||
|
2022
Q1 | $129K | Buy |
|
|||||
|
2021
Q4 | $37K | Sell |
|
|||||
|
2021
Q3 | $65K | Buy |
|
|||||
|
2021
Q2 | $24K | Sell |
|
|||||
|
2021
Q1 | $978K | Buy |
|
|||||
|
2020
Q4 | $59K | Buy |
|
|||||
|
2020
Q3 | $48K | Sell |
|
|||||
|
2020
Q2 | $42K | Sell |
|
|||||
|
2020
Q1 | $58K | Sell |
|
|||||
|
2019
Q4 | $307K | Buy |
|
|||||
|
2019
Q3 | $277K | Buy |
|
|||||
|
2019
Q2 | $161K | Buy |
|
|||||
|
2019
Q1 | $94K | Hold |
|
|||||
|
2018
Q4 | $160K | Buy |
|
|||||
|
2018
Q3 | $41K | Buy |
|
|||||
|
2018
Q2 | $9K | Buy |
|